Clinical trial
Molecular Triaging of Newly Diagnosed Breast Cancer
NCT01159236
Study timeline
Study start (unknown)2010-09-01Date precision: month
Registry last updated2012-07-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
PaclitaxelDRUG · verified · RxNorm: paclitaxel
FluorouracilDRUG · verified · RxNorm: fluorouracil
DoxorubicinDRUG · verified · RxNorm: doxorubicin
EpirubicinDRUG · verified · RxNorm: epirubicin
CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
BevacizumabDRUG · verified · RxNorm: bevacizumab
Sponsors & collaborators
M.D. Anderson Cancer Centerlead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01159236 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.